Neonatal cardiovascular pharmacology
Bell, S.G.
Neonatal Network Nn 17(2): 7-15
1998
ISSN/ISBN: 0730-0832 PMID: 9592496 Document Number: 491551
Neonates present with a variety of cardiovascular problems that require pharmacologic intervention. Pharmacologic manipulation of the ductus arteriosus and pharmacologic augmentation of cardiac output are the focus of this article. Guidelines for nursing assessment and clinical monitoring of neonates receiving cardiovascular drugs are included.
Document emailed within 1 workday
Related Documents
Lewi, P.J.; Schaper, W.K.; Van Riel, D.G.; Snoeckx, L.H.; Flameng, W.J.; Nuyens, R.F. 1973: The use of a minocomputer in cardiovascular pharmacology Arzneimittel-Forschung 23(3): 436-441Schaper, W.; Jageneau, A.; Xhonneux, R. 1970: The cardiovascular pharmacology of lidoflazine Bruxelles Medical 50(9): 635-638
Van Nueten, J.M. 1988: Cardiovascular pharmacology of serotonin and its antagonists Revue Medicale de Liege 43(Suppl 1): 22-30
Rosdahl, N.; Andersen, J.B. 1973: Aspects of the pharmacology of gentamicin during the neonatal period Acta Pathologica et Microbiologica Scandinavica. Section B: Microbiology and Immunology 1973: Suppl 241: 119
Gorczynski, R.J.; Wroble, R.W. 1982: Cardiovascular pharmacology of ASL-7022. II. Mechanisms of inotropic selectivity Journal of Pharmacology and Experimental Therapeutics 223(1): 12-19
Osborne, M.W.; Wenger, J.J.; Willems, W. 1971: The cardiovascular pharmacology of L(--)-dopa: peripheral and central effects Journal of Pharmacology and Experimental Therapeutics 178(3): 517-528
Gorczynski, R.J.; Reynolds, R.D. 1985: Cardiovascular pharmacology of ASL-7022. III. Peripheral vascular adrenergic mechanisms Journal of Pharmacology and Experimental Therapeutics 232(3): 629-635
Wu, Y.; Fang, D. 1992: Advance in pharmacology of potassium channels in cardiovascular system and their clinical use Zhonghua Yi Xue Za Zhi 72(3): 180-183
Lee, J.Y.; Rozek, L.F.; Sanner, J.H.; Radzialowski, F.M. 1983: Cardiovascular pharmacology of a calcium antagonist antihypertensive agent, SC-30552 Methods and Findings in Experimental and Clinical Pharmacology 5(4): 235-249
Lozinskiĭ, L.G.; Venediktova, M.G.; Zakharova, G.I.; Sandomirskiĭ, B.L. 1986: Development of methods for research on the clinical pharmacology of drugs used in cardiovascular diseases Farmakologiia i Toksikologiia 49(5): 60-62
Ferreira, R. 1992: First Course of cardiovascular clinical pharmacology. II. Adjuvant therapy to thrombolysis. Anticoagulants and platelet aggregation inhibitors Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(3): 261-264
Otto, C.W. 1986: Cardiovascular pharmacology. II: The use of catecholamines, pressor agents, digitalis, and corticosteroids in CPR and emergency cardiac care Circulation 74(6 Pt 2): Iv80-Iv85
Atkinson, J.; Capdeville-Atkinson, C.; Chillon, J.M.; Giummelly, P.; Lartaud-Idjouadiene, I. 1998: Cardiovascular aging: physiology, pathology, pharmacology and therapeutics. 23-24 July 1998, Faculty of Pharmacy, Nancy, France IDrugs: the investigational drugs journal 1(6): 650-651
Cosnier, D.; Duchenne-Marullaz, P.; Rispat, G.; Streichenberger, G. 1977: Cardiovascular pharmacology of bepridil (1[3 isobutoxy 2 (benzylphenyl) amino] propyl pyrrolidine hydrochloride) a new potential anti-anginal compound Archives Internationales de Pharmacodynamie et de Therapie 225(1): 133-151
Nakatsuji, K.; Kii, Y.; Fujitani, B.; Ito, T. 1990: General pharmacology of recombinant human tumor necrosis factor. 1st communication: effects on cardiovascular, gastrointestinal, renal and blood functions Arzneimittel-Forschung 40(2 Part 1): 218-225
Hermida, R.C. 1994: Biomedical pattern discrimination of neonatal cardiovascular risk Chronobiologia 21(3-4): 227-240
Khalil, H.S.; Saleh, A.M.; Subhani, S.N. 2008: Maternal obesity and neonatal congenital cardiovascular defects International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 102(3): 232-236
Díaz-Calderon, O.; Velazco-Olivares, M.; Danglot-Banck, C.; Gómez-Gomez, M.; Covarrubias-Villegas, R. 1992: Indomethacin in threatening premature labor. Fetal and neonatal cardiovascular effects Ginecologia y Obstetricia de Mexico 60: 326-330
Brandão, F.; Polónia, J. 1992: Clinical trials in cardiovascular clinical pharmacology Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(3): 273-281
Duchêne-Marullaz, P. 1977: Pharmacology, clinical pharmacology and therapeutic effects of Royat's thermal gas Semaine des Hopitaux. Therapeutique 53(7-8): 361-362